Paxil and Alimta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paxil (paroxetine hydrochloride) and Alimta (pemetrexed disodium). Common drug interactions include white blood cell count decreased among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Paxil and Alimta. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Paxil?

Paxil has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 92,546 Paxil users. Check the latest studies of Paxil.

What is Alimta?

Alimta has active ingredients of pemetrexed disodium. eHealthMe is studying from 7,702 Alimta users. Check the latest studies of Alimta.



On Aug, 07, 2026

22 people who take Paxil and Alimta together, and have interactions are studied.

Paxil and Alimta drug interactions.

What are the common drug interactions of Paxil and Alimta, by gender? *:

female:

  1. White blood cell count decreased
  2. Pneumonia
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Pyrexia (fever)
  5. Alanine aminotransferase increased
  6. Anaemia (lack of blood)
  7. Aspartate aminotransferase increased
  8. Asthenia (weakness)
  9. Blood alkaline phosphatase increased
  10. Blood glucose increased

male:

  1. Anaemia (lack of blood)
  2. Asthenia (weakness)
  3. Enteritis (inflammation of the small intestine)
  4. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  5. Genital labial adhesions (inner lips of the external female genitals (labia minora) have stuck together)
  6. Hypotension (abnormally low blood pressure)
  7. Hypovolaemia (a decreased volume of circulating blood in the body)
  8. Ingrowing nail
  9. Injection site extravasation (flow of (blood or lymph) from injection site)
  10. Interstitial lung disease

What are the common drug interactions of Paxil and Alimta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Arthralgia (joint pain)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Insomnia (sleeplessness)
  5. Nausea (feeling of having an urge to vomit)

50-59:

  1. Pneumonia
  2. Pyrexia (fever)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Abdominal pain
  5. Aggression
  6. Chest pain
  7. Device related infection
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Anaemia (lack of blood)
  2. Interstitial lung disease
  3. Nausea (feeling of having an urge to vomit)
  4. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  5. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  6. Vomiting
  7. Alanine aminotransferase increased
  8. Aortic disorder
  9. Aspartate aminotransferase increased
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. Lung Cancer Metastatic (lung cancer spreads to other parts): 8 people, 36.36%
  2. Lung Cancer - Non-Small Cell (lung cancer): 6 people, 27.27%
  3. Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 3 people, 13.64%
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 9.09%
  5. Pain: 2 people, 9.09%
  6. Non-Small Cell Lung Cancer Stage Iiib: 2 people, 9.09%
  7. Diabetes: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Paxil and Alimta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paxil and Alimta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alimta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paxil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alimta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride and pemetrexed disodium (the active ingredients of Paxil and Alimta, respectively), and Paxil and Alimta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: